Analysis of In-Hospital Mortality of Patients with New Coronavirus Infection (COVID-19) of Clinical Centre of Sechenov University

Abstract

INTRODUCTION: The epidemic of a new coronavirus infection (COVID-19) required a restructure of the entire healthcare system of the Russian Federation within a limited period of time. Here, the mortality of patients is the most important effective parameter that reflects successfulness of organization measures for improvement of the activity of medical institutions. The initial preparedness of the infrastructure permitted to rapidly deploy a hospital on the base of the Clinical Centre of Sechenov University for providing medical assistance to patients with COVID-19.

AIM: To analyze the in-hospital mortality of patients with COVID-19 at the Clinical Center of Sechenov University.

MATERIALS AND METHODS: The COVID-19 database (n = 19 230) of the Clinical Centre of Sechenov University for 2020–2022 was analyzed.

RESULTS: The overall in-hospital mortality in COVID-19 hospitals of the Clinical Centre of Sechenov University was 8.5%, which is the lower level compared to the data of foreign studies (Italy, Spain, Great Britain, USA, Iran). The main predictors of mortality are: basic — male gender, age (mainly > 75 years); existence of malignant neoplasms, diseases of the nervous system, diseases of the cardiovascular system, diseases of the endocrine system in patients; diseases occurring in the course of hospital treatment — artificial lung ventilation, past surgical interventions.

CONCLUSION: The working experience of the Clinical Center of Sechenov University shows a possibility for quick salvation of organizational tasks facing the healthcare system in the period of COVID-19 pandemic, with the results characterized by low lethality of hospitalized patients.

Keywords

new coronavirus infection / COVID-19 / pandemic / providing medical care / in-hospital mortality / clinical hospital

References

[1] Glybochko PV, Svistunov AA, Fomin VV, et al. Rol’ klinik Sechenovskogo Universiteta v okazanii pomoshchi patsiyentam s novoy koronavirusnoy infektsiyey (COVID-19). National Health Care (Russia). 2020;1(1):23–7. (In Russ).

[2] Глыбочко П.В., Свистунов А.А., Фомин В.В., и др. Роль клиник Сеченовского Университета в оказании помощи пациентам с новой коронавирусной инфекцией (COVID-19) // Национальное здравоохранение. 2020. Т. 1, № 1. С. 23–27.

[3] Glybochko PV, Fomin VV, Moiseev SV, et al. Risk factors for the early develop- ment of septic shock in patients with severe COVID-19. Therapeutic Archive. 2020;92(11):17–23. (In Russ). doi: 10.26442/00403660.2020.11.000780

[4] Глыбочко П.В., Фомин В.В., Моисеев С.В., и др. Факторы риска раннего развития септического шока у больных с тяжелым COVID-19 // Терапевтический архив. 2020. Т. 92, № 11. С. 17–23. doi: 10.26442/00403660.2020.11.000780

[5] Nikitin IG, Melekhov AV, Sayfullin MA, et al. Organizing the medical care for the COVID-19 patients in non-infectiousMoscow hospital: reassignment experience. Therapeutic Archive. 2020;92(11):31–7. (In Russ). doi: 10.26442/00403660.2020.11.000838

[6] Никитин И.В., Мелехов А.Г., Сайфуллин М.А., и др. Организация оказания медицинской помощи больным COVID-19 в неинфекционном стационаре г. Москвы: опыт перепрофилирования // Терапевтический архив. 2020. Т. 92, № 11. С. 31–37. doi: 10.26442/00403660.2020.11.000838

[7] Order of the Ministry of Health of the Russian Federation dated on 19 March, 2020 No. 198n «O vremennom poryadke organizatsii raboty meditsinskikh organizatsiy v tselyakh realizatsii mer po profilaktike i snizheniyu riskov rasprostraneniya novoy koronavirusnoy infektsii COVID-19». Available at: https://docs.cntd.ru/document/564482310. Accessed: 2023 August 31. (In Russ).

[8] Приказ Министерства здравоохранения Российской Федерации от 19 марта 2020 г. № 198н «О временном порядке организации работы медицинских организаций в целях реализации мер по профилактике и снижению рисков распространения новой коронавирусной инфекции COVID-19». Доступно по: https://docs.cntd.ru/document/564482310. Ссылка активна на 31.08.2023.

[9] Guskova ON, Dominikan IE, Volodko SN. Mortality, hospital mortality statistics and tanatological analysis of lethal outcomes in patients with new coronavirus infection (COVID-19) in Tver region. Verkhnevolzhskiy Meditsinskiy Zhurnal. 2021;20(4):8–13. (In Russ).

[10] Гуськова О.Н., Доминикан И.Е., Володько С.Н. Статистика смертности, госпитальной летальности и танатологический анализ летальных исходов у больных новой коронавирусной инфекцией (COVID-19) в Тверской области // Верхневолжский медицинский журнал. 2021. Т. 20, № 4. С. 8–13.

[11] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. doi: 10.1016/S0140-6736(20)30566-3

[12] Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study // Lancet. 2020. Vol. 395, No. 10229. C. 1054–1062. doi: 10.1016/S0140-6736(20)30566-3

[13] Kuzovlev АN, Ermokhina LV, Melnikova NS, et al. A nomogram for predicting hospital mortality in patients with COVID-19 admitted to the intensive care unit. Messenger of Anesthesiology and Resuscitation. 2022;19(1):6–17. (In Russ). doi: 10.21292/2078-5658-2022-19-1-6-17

[14] Кузовлев А.Н., Ермохина Л.В, Мельникова Н.С., и др. Номограмма для прогнозирования госпитальной летальности у пациентов с COVID-19, находившихся в отделении реанимации и интенсивной терапии // Вестник анестезиологии и реаниматологии. 2022. Т. 19, № 1. С. 6–17. doi: 10.21292/2078-5658-2022-19-1-6-17

[15] Mokrysheva NG, Shestakova MV, Vikulova OK, et al. Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020–2022 years: Russian nationwide retrospective study. Diabetes Mellitus. 2022; 25(5): 404–17. (In Russ). doi: 10.14341/DM12954

[16] Мокрышева Н.Г., Шестакова М.В., Викулова О.К., и др. Анализ рисков летальности 337 991 пациента с сахарным диабетом, перенесшего COVID-19, за период 2020–2022 гг.: всероссийское ретроспективное исследование // Сахарный диабет. 2022. Т. 25, № 5. С. 404–417. doi: 10.14341/DM12954

[17] Mityakov SN. Justification of factors influencing at the level of mortality from COVID-19. Razvitiye i Bezopasnost’. 2021;(4):4–18. (In Russ). doi: 10.46960/2713-2633_2021_4_4

[18] Митяков С.Н. Обоснование факторов, влияющих на уровень смертности от COVID-19 // Развитие и безопасность. 2021. № 4. С. 4–18. doi: 10.46960/2713-2633_2021_4_4

[19] Sagatkali AS, Tusupkaliyeva KSh, Urazayeva ST, et al. Analysis of morbidity and risk factors for mortality from COVID-19 (literature review). West Kazakhstan Medical Journal. 2022;64(1):9–17. (In Russ). doi: 10.24412/2707-6180-2022-64-9-17

[20] Сагаткали А.С., Тусупкалиева К.Ш., Уразаева С.Т., и др. Анализ заболеваемости и факторов риска смертности от COVID-19 (литературный обзор) // West Kazakhstan Medical Journal. 2022. Т. 64, № 1. С. 9–17. doi: 10.24412/2707-6180-2022-64-9-17

[21] Ssentongo P, Rastad H, Karim H, et al. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One. 2020;15(8):e0238215. doi: 10.1186/s13098-020-00565-9

[22] Ssentongo P., Rastad H., Karim H., et al. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis // PLoS One. 2020. Vol. 15, No. 8. P. e0238215. doi: 10.1186/s13098020-00565-9

[23] Lai X, Wang M, Qin C, et al. Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China. JAMA Netw Open. 2020;3(5):e209666. doi: 10.1001/jamanetworkopen.2020.9666

[24] Lai X., Wang M., Qin C., et al. Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China // JAMA Netw. Open. 2020. Vol. 3, No. 5. P. e209666. doi: 10.1001/jamanetworkopen. 2020.9666

[25] Lee LY, Cazier J–B, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919-26. doi: 10.1016/S0140-6736(20)31173-9

[26] Lee L.Y., Cazier J.–B., Angelis V., et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study // Lancet. 2020. Vol. 395, No. 10241. P. 1919–1926. doi: 10.1016/S0140-6736(20)31173-9

[27] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42. doi: 10.1001/jama.2020.2648

[28] Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention // JAMA. 2020. Vol. 323, No. 13. P. 1239–1242. doi: 10.1001/jama.2020.2648

RIGHTS & PERMISSIONS

Eco-Vector